Zera Health Tirzepatide Review: Prices and Refund Policies

Zera Health's named tirzepatide page advertises from $199 for the first month, with $315 crossed out. Lower on the same page, its treatment cards separately show $255 billed monthly and a $215-per-month label billed every three months. These are different offer descriptions; the crossed-out amount is not a confirmed renewal charge.³

For the distinction between a compounded preparation and an approved product, see our compounded tirzepatide legal-status guide.

Compare the billing interval and supplied quantity

Both treatment cards use a “5mg/10mg vial” label. That is not a personalized dose instruction or a verified supply duration. Obtain the actual quantity, total collected, eligibility conditions and next charge before selecting a plan. The quarterly equivalent does not establish a separately payable $215 monthly purchase, so ask for the full quarterly amount before paying.³

Two public policies describe different refund conditions

The page linked as Cancellation Policy offers an initial-purchase refund within seven days, only before a provider has reviewed the case or issued a prescription. It says a prescription issued and transmitted to a pharmacy cuts off refunds for that consultation fee or medication cycle. It describes cancellation taking effect at the current billing period's end and no partial-period refund.⁴

The separately linked Refund Policy requires a cancellation request at least 72 hours before billing. It says a late request leaves another charge due and cancellation takes effect in the subsequent cycle. It also says the first month is charged on completion of the intake.⁵

That second page promises a full refund for medical disqualification, but later sections discuss an unused portion and restrict approved refunds to the most recent billing cycle. Ask how those provisions apply to the selected plan. Ordinary cancellation and clinical disqualification should not be treated as the same event.⁵

Both pages remain published. Their different dates do not establish which governs an actual purchase. Obtain the applicable policy and selected-plan terms in writing before paying.^4,5

The OrderlyMeds review provides a prescription-stage comparison: its FAQ separates clinical nonapproval from cancellation after a prescription is finalized, with a separate multi-month exception. Compare that cutoff with the actual Zera policy that governs your purchase.⁷

Published pharmacy names and clinical roles

The Refund Policy FAQ names Strive Pharmacy, with coordination through TelegraMD. It also says included consultations, labs and medication vary by plan. These are provider-published descriptions, not independent confirmation of an assigned facility, current license or guaranteed clinician response time. Zera's footer identifies it as a technology platform and leaves prescribing decisions to licensed clinicians.⁵

Clinical evidence and individual care

Clinical studies concern specific products and treatment protocols. They do not establish outcomes for this service or equivalence of an individual compounded preparation.^1,2 If a compounded preparation is prescribed, it is not an FDA-approved finished medicine.⁶ Confirm the actual prescription, supplied quantity and dispensing instructions with the prescriber and pharmacist.

The tirzepatide evidence guide explains the research context. Discuss the side-effect profile, gallbladder risks and thyroid cancer warning with the prescribing clinician; a seller’s price does not determine clinical suitability.

Compare the care and payment commitment

Compare the billing commitment and pharmacy information in our Vitara Rx review and VyraRx review. Their terms do not resolve which Zera policy governs your purchase.

Use the tirzepatide provider comparison to compare published medication options and payment terms.